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Abstract
Introduction: This study was aimed at deciphering the secretome of adipose-derived mesenchymal stromal cells
(ADSCs) cultured in standard and hypoxic conditions to reveal proteins, which may be responsible for regenerative
action of these cells.
Methods: Human ADSCs were isolated from 10 healthy donors and cultured for 3–4 passages. Cells were serum
deprived and cell purity was assessed using multiple cell surface markers. Conditioned media was collected and
analyzed using LC-MS with a focus on characterizing secreted proteins.
Results: Purity of the ADSC assessed as CD90+/CD73+/CD105+/CD45-/CD31- cells was greater than 99 % and viability
was greater than 97 %. More than 600 secreted proteins were detected in conditioned media of ADSCs. Of these 100
proteins were common to all cultures and included key molecules involved in tissue regeneration such as collagens
and collagen maturation enzymes, matrix metalloproteases, matricellular proteins, macrophage-colony stimulating
factor and pigment epithelium derived factor. Common set of proteins also included molecules, which contribute to
regenerative processes but were not previously associated with ADSCs. These included olfactomedin-like 3, follistatin-
like 1 and prosaposin. In addition, ADSCs from the different subjects secreted proteins, which were variable between
different cultures. These included proteins with neurotrophic activities, which were not previously associated with
ADSCs, such as mesencephalic astrocyte-derived neurotrophic factor, meteorin and neuron derived neurotrophic
factor. Hypoxia resulted in secretion of 6 proteins, the most prominent included EGF-like repeats and discoidin I-like
domains 3, adrenomedullin and ribonuclease 4 of RNase A family. It also caused the disappearance of 8 proteins,
including regulator of osteogenic differentiation cartilage-associated protein.
Conclusions: Human ADSCs with CD90+/CD73+/CD105+/CD45-/CD31-/PDGFRβ+/NG2+/CD146+(−) immunophenotype
secrete a large array of proteins, the most represented group is comprised of extracellular matrix components.
Number of secreted proteins is largely unaffected by prolonged hypoxia. Variability in the secretion of several
proteins from cultured ADSCs of individual subjects suggests that these cells exist as a heterogeneous population
containing functionally distinct subtypes, which differ in numbers between donors.
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Introduction
Multipotent mesenchymal stromal cells, isolated from
bone marrow or adipose tissue (ADSC), enhance tissue
regeneration upon transplantation [1], by guiding the
amplification and differentiation of resident stem cells
as well as by stimulating the growth of blood vessels
and nerves [2–4]. Recent studies indicated that ADSCs
effects on regeneration are mostly mediated by their
ability to produce a wide range of bioactive molecules
(growth factors, cytokines, etc.) [5, 6] as well as extra-
cellular vesicles [7]. Therefore, the secretome of cul-
tured ADSCs was suggested as an alternative for cell
therapy and many efforts to decipher its contents were
made using various approaches (reviewed in [8]). Sev-
eral candidate factors, which mediate the beneficial
effects of the ADSCs secretome on tissue regeneration,
were identified, including vascular endothelial growth
factor (VEGF), hepatocyte growth factor (HGF), insulin-
like growth factor ( IGF-1), platelet-derived growth factor
(PDGF-BB), angiopoietin-like 4 protein, and brain-
derived neurotrophic factor (BDNF) [9, 10]. However,
the content of factors necessary for the stimulation of
tissue regeneration by ADSCs remains only partially
characterized. The efficiency of ADSC-based therapies
varies between different donors, but the results of the
experimental and clinical studies analyzing the impact
of donor-specific factors, including age, sex and concomi-
tant disorders, on the efficiency of cell therapy were
controversial [11–14]. Molecular mechanisms underlying
donor-dependent variations of ADSC activities remain
to be elucidated as well as a set of biomarkers, which
would allow predicting ADSCs regenerative activity in
vivo.
Several authors including us have used hypoxia as a
tool to further enhance the regenerative potential of
ADSCs, because hypoxic treatment caused coordinated
changes of expression of genes involved in the stimula-
tion of regeneration [15–17]. We analyzed secretomes of
ADSCs derived from ten healthy female donors of similar
age cultured in standard (21 % O2) or hypoxic (1 % O2)
conditions. More than 600 secreted proteins were de-
tected in conditioned media of ADSCs, many of which
may promote tissue regeneration; their number is largely
unaffected by prolonged hypoxia. Despite an identical
immunophenotype, growth characteristics and differ-
entiation abilities, only 100 proteins were common to
all cultures. In addition, ADSCs from the different sub-
jects secreted proteins which were variable between
different cultures, including ones responsible for tissue
regeneration. Variability in the secretion of several pro-
teins by ADSCs of individual subjects suggests that
these cells exist as a heterogeneous population con-
taining functionally distinct subtypes which differ in
numbers between patients.
Methods
ADSCs culture and conditioned medium harvesting
Human ADSCs were isolated from subcutaneous adi-
pose tissue obtained from ten female donors during
abdominal surgery [1]. All donors gave their informed
consent and the local ethics committee of city clinical
hospital #31 (Moscow, Russia) approved the study proto-
col. All donors were < 50 years old and did not have
obesity or acute inflammation (Additional file 1: Table S1).
All ADSC cultures were isolated from the same fat depot.
This significantly limited the size of the initial sample. There-
fore, we had to culture cells up to the third or fourth pas-
sages to collect a sufficient amount of material for analysis.
Cells were cultured in AdvanceSTEM Mesenchymal Stem
Cell Media containing 10 % AdvanceSTEM Supplement
(HyClone, South Logan, Utah, USA), 1 % antibiotic–antimy-
cotic solution (HyClone) at 37 °C in 5 % CO2 incubator.
Cells were passaged at 70 % confluency using HyQTase solu-
tion (HyClone). For the experiments, ADSCs of the third or
fourth passages were seeded at a density of 7x103 cells/cm2
on uncoated culture plates (Corning, NY, USA) a day before
the experiment. ADSCs were washed thoroughly five times
with HBSS without Ca2+ and Mg2+ supplemented with x100
MEM amino acid (Gibco, Waltham, MA USA) on a rotary
platform placed in a CO2 incubator to remove any residues
of AdvanceSTEM Supplement. After the last wash, HBSS
was replaced by serum-free AdvanceSTEM Mesenchymal
Stem Cell Media supplemented with x100 MEM amino acid
(Gibco). For assessment of secretome content ADSCs were
cultured either under standard conditions (5 % CO2 and
21 % O2) or under hypoxia (5 % CO2 and 1 % O2) at 37 °C
for 48 h [18]. At the end of the incubation, conditioned
medium was harvested and cultured cells were subjected
to an analysis of immunophenotype and viability. The vol-
ume of harvested medium was measured and 100 mM
PMSF solution and 200 mM EDTA solution were added
to 2 and 5 mM concentration, respectively. Cell debris
was removed by centrifugation for 15 min at 200 g. The
resulting supernatant was filtered through a 0.45 μm filter
(BD Falcon, San Jose, CA, USA) and snap-frozen in liquid
N2. The quantity and viability of the ADCSs were assessed
at the end of the experiment using a Countess cell counter
(Invitrogen, Waltham, MA, USA).
ADSCs immunophenotyping
The limited size of starting material did not allow us to
perform immunophenotype analysis before the initial
plating of cells. To confirm that ADSCs are multipotent
mesenchymal stromal cells we analyzed their immuno-
phenotype according to published criteria [19]. For
phenotypic analysis cells were stained with four differ-
ent antibody combinations: (1) CD45/IgG-PE/IgG-Per
CP-Cy5.5/IgG-PC5; (2) CD45/СD7-PE/IgG-PerCP-Cy5.
5; (3) CD45/CD73-PE/CD105-PerCP-Cy5.5; and (4) CD
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45/IgG-PE/CD90-PC5. For patients 7–10 CD90-PC5
was replaced with CD90-PE and IgG-PC5 was removed.
Cells from patients 2–9 were additionally stained with
antibodies against neuro-glial proteoglycan 2 (NG2-
FITC, Chemicon), platelet-derived growth factor recep-
tor B (PDGFRB-PE, BD Pharmingen), CD31-Alexa647
(BD Pharmingen, San Jose, CA, USA), CD34-PerCP (BD
Pharmingen), and CD146-PE (BD Pharmingen). After 1 h
staining at +4 °C cells were washed once with PBS and an-
alyzed live within 1 h using a LSR Fortessa flow cytometer
(BD Biosciences) and FACSDiva software (BD). PerCP-
Cy5.5 and PC5 were analyzed with 640 nm red laser exci-
tation that directly excite Cy5.5 or Cy5 dye and 710–
750 nm emission filter.
ADSCs differentiation assays
ADSCs abilities to differentiate into osteogenic and adipo-
genic directions were tested in vitro using standard differ-
entiation and analysis protocols [11] in a normoxic
environment. Briefly, osteogenic differentiation was induced
by plating 6×104 of ADSCs onto a 24-well plate and incu-
bating in AdvanceSTEM Mesenchymal Stem Cell Media
containing 10 % AdvanceSTEM Supplement (HyClone),
1 % antibiotic–antimycotic solution (HyClone), containing
10−8 М dexamethasone, 10 mМ β-glycerol-2-phosphate,
0.2 mМ 2-phospho-L-ascorbic acid (Invitrogen, USA) for
21 days. Differentiation efficiency was analyzed using Ali-
zarin Red S staining for calcium accumulation. Adipogenic
differentiation was induced by three cycles of consecutive
incubation for six days in growth medium containing 10−6
М dexamethasone, 10 μM insulin, 200 μM indomethacin
and 0.5 mM 3-isobutyl-1-methylxanthine (Invitrogen,
USA) followed by three days incubation in growth medium
containing 10 μM insulin. Cells accumulated intracellular
lipids which were analyzed using Oil-Red-O staining.
Gel-free digestion of the protein sample with DTT
The pellet was resuspended in 50 μl 100 mM ammo-
nium bicarbonate with 10 mM DTT (BioRad, Hercules,
California, USA) and 1 μl protease inhibitor Mix (GE
Healthcare, Pittsburgh, PA, USA), mixed in a vortex, and
heated at 100 °C for five min. After cooling to room
temperature, the insoluble material was removed by cen-
trifugation at 15,000 g for five min. Supernatant was sep-
arated and protein concentration was determined by
Bradford (Bradford Protein Assay Kit, BioRad). In the
supernatant, reduced protein disulfide bonds were alky-
lated with 30 mM iodoacetamide (BioRad) in 100 mM
ammonium bicarbonate at room temperature and in the
dark for 30 min and 10 mM DTT (BioRad) in 100 mM am-
monium bicarbonate was added iteratively. Upon alkylated
trypsin (Trypsin Gold, Mass Spectrometry Grade, Promega,
Madison, WI, USA) in ratio trypsin:protein equal 1:30 was
added to the supernatant and incubated at 37 °C overnight.
For inactivation of trypsin activity a stock solution of tri-
fluoroacetic acid (Sigma, St. Louis, MO, USA) (final con-
centration in sample 0.5 %) was added to the digest.
Small amounts of the digest for liquid chromatography/
mass spectrometry (LC-MS) analysis were desalted on
ZipTip (Millipore, Billerica, MA, USA).
Liquid chromatography/mass spectrometry analysis and
protein identification
Analysis was performed on a TripleTOF 5600+ mass-
spectrometer with a NanoSpray III ion source (ABSciex,
Concord, Ontario, Canada) coupled to a NanoLC Ultra
2D+ nano-HPLC system (Eksigent, Concord, Ontario,
Canada). The high-performance liquid chromatography
(HPLC) system was configured in a trap-elute mode. For
a sample loading buffer and buffer A, the mix of 98.9 %
water, 1 % methanol, 0.1 % formic acid (v/v) was used.
Buffer B was 99.9 % acetonitrile, 0.1 % formic acid (v/v).
The trap column was conditioned prior to use by the
same solvent as the column itself (95 % of solution A
(H20 + 1 % MeOH+ 0.1 % formic acid) and 5 % of solu-
tion B (AcN + 0.1 % formic acid) during 25 min with a
flow rate of 300 nl/min.
Samples were loaded on a trap column Chrom XP
C18 3 microm 120 Å 350 microm*0.5 mm (Eksigent,
Dublin, CA, USA) at a flow rate of 3 ul/min over 10 min
and eluted through the separation column 3C18-CL-120
(3 microm 120 Å) 75 microm*150 mm (Eksigent) at a
flow rate of 300 nl/min. The gradient was from 5 to
40 % of buffer B in 120 min. The column and the pre-
column were regenerated between runs by washing with
95 % of buffer B for seven min and equilibrated with
5 % of buffer B for 25 min. To ensure the absence of
carryover both the column and the precolumn were
thoroughly washed with a blank trap-elute gradient that
included five seven-min 5-95-95-5 %B waves followed by
25 min 5 % buffer B equilibration between different
samples.
Mass spectra were acquired in a positive ion mode.
The information-dependent mass-spectrometer experi-
ment included one survey MS1 scan followed by 50
dependent MS2 scans. MS1 acquisition parameters were
as follows: mass range for analysis and subsequent ion
selection for MS2 analysis was 300–1250 m/z, signal ac-
cumulation time was 250 ms. Ions for MS2 analysis were
selected on the basis of intensity with the threshold of
250 cps and the charge state from 2 to 5. MS2 acquisi-
tion parameters were as follows: resolution of quadru-
pole was set to UNIT (0.7 Da), measurement mass range
was 200–1800 m/z, optimization of ion beam focus was
to obtain maximal sensitivity, signal accumulation time
was 50 ms for each parent ion. Collision activated dis-
sociation was performed with nitrogen gas with collision
energy ramping from 25 to 55 V within 50 ms signal
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accumulation time. Analyzed parent ions were sent to a
dynamic exclusion list for 15 s in order to get an MS2
spectra at the chromatographic peak apex (minimum
peak width throughout the gradient was about 30 s).
Instrument reproducibility is controlled during routine
process and technical duplicates were not run. Temporal
biases were not reduced.
For protein identification, .wiff data files were analyzed
with ProteinPilot 4.5 revision 1656 (ABSciex) using the
search algorithm Paragon 4.5.0.0 revision 1654 (ABSciex)
and a standard set of identification settings to search
against Uniprot Swissprot (dated 20131002) database. The
following parameters were used: alkylation of cysteine -
iodoacetamide, trypsin digestion, TripleTOF 5600 equip-
ment, and species: Homo sapiens, thorough search with
additional statistical FDR analysis. Peptide identifications
were processed with default settings by a ProteinPilot soft-
ware built-in ProGroup algorithm. Our approach allows
us to detect 90 % of peptides with a concentration > 5
fMol and 1,500 of the most presented proteins. The final
protein identification list was obtained with the threshold
reliable protein ID unused score calculated by ProteomicS
Performance Evaluation Pipeline Software (PSPEP) algo-
rithm for 1 % global FDR from fit and with the require-
ment for more than two unique peptides for each protein.
RNA isolation and transcriptome analysis
To confirm the expression of identified proteins, we
performed gene array experiments. Total cellular RNA
was isolated from normoxic ADSCs using a RNeasy Kit
(Qiagen, Venlo, The Netherlands, cat # 74104) according
to the manufacturer’s instructions. Five hundred nano-
grams of total RNA was labeled and hybridized on
HumanHT-12 v4 Expression BeadChip (Cat. no. BD-103-
0204; Illumina, San Diego, CA, USA), according to the
manufacturer’s recommendations (Illumina Gene Expres-
sion Profiling Assay Guide). BeadChips were scanned with
the Illumina iScan Reader. Data were imported into Geno-
meStudio (Illumina) and analyzed using built-in mod-
ules. Signals with detection p value <0.05 were
considered as significant.
Real-time PCR
To confirm changes of protein content under hypoxic
treatment, we performed real-time PCR using total RNA
isolated from normoxic and hypoxic ADSCs. cDNA was
synthesized using Fermentas Reverse Transcription Re-
agents (Fermentas, Vilnius, Lithuania) with oligo-dT and
RevertAid™ M-MuLV Reverse Transcriptase (Fermentas)
according to the manufacturer’s instructions. Real-time
PCR was performed using ready-to-use reaction mix, con-
taining DNA polymerase, SYBR Green and ROX (Evro-
gen, Moscow, Russia) in 7500 Fast Real-time PCR system
(Applied Biosystems, South Logan, Utah, USA). The
following oligonucleotide primers were used for
amplification:
VEGFA: forward CAACATCACCATGCAGATTATGC,
reverse GCTTTCGTTTTTGCCCCTTTC; EDIL: forward
AAATGGAGGTATCTGTTTGCCAG, reverse CCCCTC
GGTATGCTTCACTTATT; RNASE4: forward TGCAGA
GGACCCATTCATTGC, reverse TCAAGTTGCAGTAG
CGATCAC; ADML: forward TGCCCAGACCCTTATTC
GG, reverse AGTTGTTCATGCTCTGGCGG; CRTAP:
forward GAAGCATCCTGATGACGAAATGA, reverse A
GTTCTCACCGTTGTATGCCC; HSP90AB2P: forward
AGTTGGACAGTGGTAAAGAGCT, reverse TCCACTA
CTTCTTTGACCTGCA; GCSF: forward CCCTCCCCA
TCCCATGTATTTATC, reverse ACCTATCTACCTCCC
AGTCCAG; EEF1A1: forward TGTCGTCATTGGACA
CGTAGA, reverse ACGCTCAGCTTTCAGTTTATCC.
Fold change of mRNA expression in hypoxic samples
was calculated using the 2-ΔΔCt method, EEF1A1 was
used as a reference gene.
Protein electrophoresis and Western blotting
To confirm ADSC response to hypoxia, HIF-1 alpha
content was analyzed using Western blotting. Protein
electrophoresis was carried out under denaturing condi-
tions with sodium dodecyl sulfate according to Laemmli
[20]. Cells lysed in buffer with 1 % Triton X-100 were
separated in 10 % 1 mm PAAG (30 μg of protein per
lane) at 120 V before the tracking dye release. Protein
molecular weight was estimated using a pre-stained pro-
tein ladder (BioRad). Separated proteins were transferred
to a PVDF membrane (Millipore) by semi-dry electro-
blotting [21] at 25 V for 45 min in buffer for protein
transfer. The membrane with transferred protein was
incubated in phosphate buffer (PBS) with 5 % fat-free
milk and 0.01 % Tween-20 for 1 h. The membrane was
incubated with primary mouse monoclonal antibodies to
HIF-1 alpha (Abcam, Cambridge, UK) overnight,
followed by four washes in PBS with 0.01 % Tween-20.
Then membranes were incubated with secondary anti-
mouse antibodies conjugated with horseradish peroxid-
ase (R&D) and washed with PBS with 0.01 % Tween-20.
Protein bands were visualized with BioMax roentgen
film (Kodak, Rochester, NY, USA) by a chemilumines-
cence technique. Luminescence was initiated by luminol
reaction with hydrogen peroxide (ECL, Amersham,
Pittsburgh, PA, USA) catalyzed by horseradish peroxid-
ase conjugated with secondary antibodies. Protein
amounts in samples were normalized by GAPDH pro-
tein content.
Enzyme-linked immunosorbent assay
ADSC secretomes were analyzed for accumulation of
granulocyte-colony stimulating factor (G-CSF) using
Quantikine enzyme-linked immunosorbent assay (ELISA)
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Fig. 1 Representative flow cytometry plots of MSC surface markers expression on ADSC obtained from ten different donors. Plots from left to right in
each row: forward and side scattered plot of analyzed population; CD45 expression; control IgGs staining; CD73 expression; CD73 and CD105 expression;
CD90 expression. MSC mesenchymal stromal cells, ADSC adipose-derived mesenchymal stromal cells
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(#DCS50, R&D Systems, Minneapolis, MN, USA) accord-
ing to the manufacturer’s instructions. Concentration of
G-CSF in individual samples was normalized to total pro-
tein concentration measured by Bradford assay.
Statistics and bioinformatics
Identified proteins were analyzed for the possibility of
secretion using SignalP (http://www.cbs.dtu.dk/services/
SignalP), SecretomeP (http://www.cbs.dtu.dk/services/Se
cretomeP) and ExoCarta (http://www.exocarta.org) data-
bases and further subjected to bioinformatic analysis. To
determine over-represented proteins for both hypoxia
and control samples we used a hypergeometric test (con-
fidence level P-value < = 0.05). Functional annotation
clustering was performed using DAVID Bioinformatics
Resources 6.7 (https://david.ncifcrf.gov), using default set-
tings. Functional clusters with p-value <0.05 were consid-
ered strongly enriched in the annotation categories [22].
Statistical analysis of real-time PCR and ELISA data
was performed using Statistica 8.0 software. Values are
expressed as mean ± standard error of the mean (SEM).
Data were assessed for normality of distribution using the
Kolmogorov-Smirnov test. Differences between treatment
and control groups were then analyzed using Student’s t-
test. Statistical significance was defined as p-value <0.05.
Results
Characterization of ADSCs secretomes
ADSCs of third or fourth passages cultured in serum-
free medium for 48 h demonstrated more than 97 %
viability at the end of the incubation, and > 99 % of
these cells possessed CD105+CD73+CD90+CD45− immu-
nophenotype (Fig. 1) suggested for multipotent mesenchy-
mal stromal cells [19]. They were capable of osteogenic and
adipogenic differentiation (Additional file 2: Figure S1).
More than 90 % of these cells expressed the perycite
markers PDGFRβ and NG2 proteoglycan. In contrast to
these proteins, the expression of CD146 antigen varied
between ADSCs populations from different donors, 22 ±
14.5 % of cells were positively stained with specific antibody
(Additional file 3: Figure S2). Using LC-MS, 606 secretory
proteins were identified in ADSCs conditioned medium
(for protein catalogue see Additional file 1: Table S2). Of
these, 452 proteins were considered as secreted through a
classical pathway (endoplasmic reticulum/Golgi apparatus-
dependent pathway), because a signal peptide was predicted
by the Signal Peptide Database, while 157 proteins were
secreted through nonclassical pathways. The expression of
mRNAs corresponding to the identified proteins was
confirmed using Illumina Gene Expression Profiling Assay
(Additional file 4: Table S3).
Despite similar anthropometric characteristics of donors
included in the study, the same culture conditions, growth
characteristics, immunophenotype and differentiation
potential of ADSCs, only 100 proteins were common to
all cultures (Additional file 1: Table S4). Functional anno-
tation clustering has revealed 72 clusters. Those with the
highest enrichment score and protein counts included
extracellular matrix (ECM) proteins, proteins involved in
cell adhesion, and matrix proteases as well as their inhibi-
tors (Table 1 and Additional file 1: Table S4). Proteins
common to all ADSC cultures also included molecules in-
volved in blood vessel development, wound healing, im-
mune response, and neuron projection development
and regeneration, such as M-CSF, PEDF, DKK3,
olfactomedin-like 3, follistatin-like 1, and prosaposin
(Table 1 and Additional file 1: Tables S2 and 4).
In addition to common proteins, ADSCs from differ-
ent subjects secreted proteins, which varied between
different cultures (Additional file 1: Table S4). Together
common and variable proteins secreted by ADSCs fit
over 400 GO terms with p value <0.05. Interestingly, terms
with the highest protein counts matched GO terms identi-
fied for common proteins. Thus, 101 ECM proteins were
identified in ADSCs secretomes (GO:0005578 ~ protein-
aceous extracellular matrix, see Additional file 1: Table S5
for proteins list), which corresponds to 30 % of all known
human proteins included in this category. Overall, ADSCs
secretomes contained 41 proteins involved in blood vessel
development (see Additional file 1: Table S6 for proteins
list) and 24 proteins grouped into GO:0030182 ~ neuron
differentiation term (see Additional file 1: Table S7). These
included angiopoietin-like 2 and −4, gremlin-1 and −2,
inhibin A, IGFBP 3–7 and −10, IL-6 and −8, SCF, MIF,
urokinase, SDF-4, PDGF-D and VEGF-C. Several proteins,
which were not previously associated with ADSCs were
also found in their secretomes. These included proteins
with neurotrophic activities, such as caprin 1, mesenceph-
alic astrocyte-derived neurotrophic factor, meteorin and
neuron derived neurotrophic factor.
ADSCs secretome content is largely unaffected by
prolonged hypoxia
To enhance the secretion of proteins involved in tissue
regeneration, we subjected ADSCs to hypoxia (1 % O2
for 48 h) [18]. Cells responded to hypoxia in a similar
manner, by 5.6 ± 0.4 fold up-regulation of the content of
HIF-1α (Additional file 5: Figure S3) as well as by 2.82 ±
1.28 fold elevation of known HIF-1α target VEGFA
mRNA. In secretomes of hypoxic ADSCs 616 secretory
proteins were identified; 480 of these were considered to
be secreted through a classical pathway, while 142 proteins
were secreted through nonclassical pathways (Table 2,
Additional file 5: Figure S3). Overall, ADSC incubation in
hypoxia resulted in secretion of six proteins which were
not found in normoxic secretomes (Table 3). These in-
cluded proteins involved in the regulation of angiogenesis,
such as EGF-like repeats and discoidin I-like domains 3
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Table 1 Functional categories of common proteins identified in all normoxic ADSC secretomes
GO term Counta % P
value**
Proteins (Uniprot acc no.) Examples
GO:0005578 ~ proteinaceous
extracellular matrix
41 41.4 <0.001 P02751, P05997, P01033, P20908, P27797,
Q99715, P02461, Q16610, P16035, P09486,
P28300, P07942, P11047, P98160, P98095,
P12110, P14543, P12111, Q9UBX5, P02452,
P23142, P55268, Q16363, P35555, Q15582,
P08123, O95967, P07585, P24821, P51884,
P12109, P08254, P08253, Q08629, P21810,
Q12805, Q15063, Q08380, Q14767, P13611,
P03956
Collagens, collagen-maturation enzymes,
collagen interacting proteins, elastin-
associated molecules, matricellular
proteins, laminins
GO:0005509 ~ calcium ion
binding
35 35.4 <0.001 Q02818, P35442, P19022, P27797, P09871,
Q92626, P12814, P09486, P11021, O43707,
P07996, P98095, P00736, P14543, Q9UBX5,
Q15293, P23142, Q12841, P80303, P15289,
P35555, O95967, O94985, Q9BRK5, P06396,
P13497, P08254, P08253, Q08629, P67936,
Q12805, O43852, Q14767, P13611, P03956
calsyntenin 1; heat shock 70 kDa protein 5;
reticulocalbin 1; stromal cell derived factor
4; calumenin; nucleobindin 1,2; calreticulin
GO:0007155 ~ cell adhesion 31 31.3 <0.001 Q16270, P35442, P02751, P20908, P19022,
Q99715, P02461, P12814, P07942, P11047,
P07996, P98160, P12110, P12111, P14543,
Q9UBX5, P05067, P55268, Q16363, Q15582,
P35579, O94985, P24821, Q8IUX7, P13497,
P12109, Q08629, Q15063, Q08380, O14498,
P13611
Lectin 3 binding protein; BMP1; AE binding
protein 1;N-cadherin; IGFBP-7; TGFBIP
GO:0006928 ~ cell motion 14 14.1 <0.001 P02751, P20908, P19022, P60709, P05067,
P35579, Q13822, P09493, P06753, Q08629,
P67936, P11047, P07996, P13611
Extracellular lysophospholipase
D; tropomyosins 1, 3, 4
GO:0008233 ~ peptidase
activity
13 13.1 <0.001 P30101, O14773, P16870, P07858, P09871,
P05067, Q8IUX7, P13497, P08254, P08253,
P05121, P03956, P00736
MMP1, 2; carboxypeptidase E; cathepsin
B; tripeptidyl peptidase I
GO:0004866 ~ endopeptidase
inhibitor activity
12 12.1 <0.001 P16035, P36955, P01033, P12111, P05155,
P05121, P11021, P50454, P05067, P07093,
Q6YHK3, P01034
PEDF; TIMP1,2; PAI-1, 2; cystatin C
GO:0001568 ~ blood vessel
development
11 11.1 <0.001 P20908, P19022, P08253, P02452, P28300,
P21810, Q16363, P02461, P07996, P35579,
P08123
N-cadherin; thrombospondin 1, 2; biglycan;
lysyl oxidase
GO:0042060 ~ wound healing 10 10.1 <0.001 P02751, P09493, P20908, P05155, P06396,
P05121, Q9UBX5, P28300, P02461, O95967
Fibulins 4, 5; collagen, type III; fibronectin 1
GO:0006955 ~ immune
response
10 10.1 0.037 P61769, P05155, P26022, O75326, P10909,
P09871, Q92626, P07996, Q13822, P00736




7 7.1 <0.001 P05997, P13497, P08253, P09486, P02452,
P17936, P98160
Perlecan; osteonectin; BMP1; IGFBP 3
GO:0031175 ~ neuron
projection development
6 6.1 0.027 P10909, P07942, P60709, P05067, P55268,
P13611
Versican; amyloid beta (A4) precursor
protein
GO:0060284 ~ regulation of
cell development
5 5.1 0.046 P16035, P36955, P19022, P27797, P17936 N-cadherin; PEDF; TIMP2; IGFBP 3





4 4 0.030 Q12841, P02461, P08123, Q14767 CD109; DKK3; follistatin-like 1
GO:0016860 ~ intramolecular
oxidoreductase activity
3 3 0.027 P30101, P07237, P41222 prolyl 4-hydroxylase; prostaglandin D2
synthase
ADSC adipose-derived mesenchymal stromal cells, GO Gene Ontogeny, TGFBIP transforming growth factor, beta-induced, 68 kDa, IGFBP insulin-like growth factor
binding protein
aProteins annotated to different functional clusters partially overlap
**p value according to kappa statistics (DAVID Bioinformatics Resources, https://david.ncifcrf.gov) [22, 47]
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(EDIL), ribonuclease 4 of RNase A family and adrenome-
dullin. Eight proteins were found in hypoxic samples less
frequently compared to normoxia (Table 3). Using real-
time PCR we confirmed that hypoxia has affected the
expression of corresponding mRNAs (Fig. 2). We also ex-
amined if hypoxia affects the expression of rarely detected
proteins such as G-CSF, which was found only in one
hypoxic but not in normoxic secretomes. Concentration of
G-CSF in secretomes of normoxic ADSC was 13.4 ± 8.5
fmol, which is close to the detection limit of LS/MS ana-
lysis. In hypoxia, G-CSF mRNA and protein were up-
regulated 1.7 ± 0.3 and 1.9 ± 0.5 fold, respectively (Fig. 3).
Protein distribution by functional clusters in hypoxic
secretomes was similar to normoxia and the rank order
or significance of functional clusters did change between
normoxic and hypoxic conditions. The most represented
group was GO:0005578 ~ proteinaceous extracellular
matrix (98 proteins). Within this cluster four additional
proteins were detected, which have not been found in
normoxic secretomes. However, these were found only
in one or two secretomes each (of different donors);
therefore, this finding must be considered with caution.
At the same time, seven ECM proteins, which have been
detected in normoxic secretomes were not found in hyp-
oxic samples (Additional file 1: Table S5). The disappear-
ence of only one of these, namely cartilage associated
protein (CRTAP) was significant (Table 3); other pro-
teins were found only in one or two normoxic secre-
tomes each.
Discussion
Since ADSCs are promising material for cell therapy
and tissue engineering, their secretome has been ana-
lyzed in many studies using various qualitative and
quantitative approaches (for details see [8, 23] and ref-
erences therein) in order to understand the physiology
of these cells. Our data are consistent with published
observations regarding ADSCs secretome content and
provide an expansion of known catalogues of proteins
secreted by ADSCs. Thus, 75 % of identified secretory
proteins possess a signal peptide and, therefore, are likely
to be secreted by classical ER-Golgi apparatus pathway
[24]. Other proteins are suggested to undergo unconven-
tional secretion, via non-vesicular and vesicular pathways
[25]. For example, annexin A2, which was found in the
most secretomes analyzed in the current study, is pro-
duced via direct translocation across the plasma mem-
brane [26]. ADSCs secretomes also contain proteins
secreted via exosomes (e.g., inhibin A and SCF [7]) and
through so called “Golgi bypass” (eg., serglycin [27]).
Table 2 ADSC secretomes overview
Parameter Normoxia Hypoxia
Total number of proteins found in secretomes 608 620
Number of common proteins shared by all
secretomes
100 79
Number of classically secreted proteins 451 480
Number of proteins secreted via nonclassical
pathways
157 140
Number of overrepresented proteins* 7 2
Number of unique proteinsa 1 4
ADSC adipose-derived mesenchymal stromal cells
aproteins found only in normoxic or hypoxic secretomes (>3 samples, p >0.1)
*p <0.1 (hypergeometric test)
Table 3 Overrepresented proteins in secretomes of normoxic or hypoxic ADSCs
Uniprot_acc # Protein name P value
Proteins overrepresented in secretomes of normoxic ADSCs
P35556 fibrillin 2 0.08
P35052 glypican 1 0.07
P29401 transketolase 0.08
O75718 cartilage associated protein 0.04
P48723 heat shock protein 70 kDa family, member 13 0.08
Q14257 reticulocalbin 2, EF-hand calcium binding domain 0.08
P30048 peroxiredoxin 3 0.08
Q9UL46 proteasome activator subunit 2 (PA28 beta) 0.07
Proteins overrepresented in secretomes of hypoxic ADSCs
Q8N6G6 ADAMTS-like 1 0.04
P19823 inter-alpha (globulin) inhibitor H2 0.04
O43854 EGF-like repeats and discoidin I-like domains 3 0.1
P34096 ribonuclease, RNase A family, 4 0.1
P35318 adrenomedullin 0.1
P78324 Tyrosine-protein phosphatase non-receptor type substrate 1 (SIPRA) 0.1
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Most previous proteomic studies have analyzed the
content of pooled secretomes rather than of samples
obtained from individual donors [8, 23]. This study
indicates that despite similar characteristics, which are
routinely assessed for ADSCs, including their differen-
tiation abilities and stromal immunophenotype [19],
these cells can differ in the spectrum of produced pro-
teins. Such differences could be explained by the pres-
ence of multiple subtypes specialized in the production
of particular proteins. Here we demonstrate that ana-
lyzed ADSCs cultures differ in the proportion of cells
expressing CD146 (MCAM) surface antigen. Further-
more, other membrane proteins, including receptors for
hormones and neuromediators could possibly serve as de-
finitive markers for such ADSC subpopulations [28]. Fu-
ture proteomic analysis of ADSC subpopulations purified
according to the expression of those markers is important
as it can reveal cells with specialized activities. The usage
of such purified cells will allow an increase in the effi-
ciency of ADSC clinical applications and reduce possible
side effects.
Consistent with other reports, the largest functional
cluster in the ADSC secretome is comprised of ECM
proteins. Such protein profile is in line with the stromal
characteristics of ADSCs. Adequate production of ECM
components is necessary for tissue homeostasis and re-
generation [29, 30], because these molecules not only
provide a scaffold for cells and soluble molecules, but
also regulate angiogenesis and inflammation (i.e., throm-
bospondin 1 [31], periostin [32], and collagen-derived
peptides).
Among proteins common to all ADSC secretomes sev-
eral molecules not previously associated with ADSCs
were identified, including DKK3, olfactomedin-like 3,
follistatin-like 1, and prosaposin. These molecules might
also contribute to tissue morphogenesis and regeneration
induced by ADSCs [33–35]. For example, olfactomedin-
like 3 was demonstrated to be important for tumor angio-
genesis and vessel stabilization [34]. Considering these
data, we can suggest that olfactomedin-like 3 is important
for the ability of ADSCs to stimulate the growth of blood
vessels. Among variably present molecules, we found
several proteins with neurotrophic activities, such as
caprin 1, mesencephalic astrocyte-derived neurotrophic
factor, meteorin, and neuron derived neurotrophic fac-
tor. These factors, together with neurotrophins previ-























EDIL3 RNASE4 ADM CRTAP HSP90AP
A B
Fig. 2 Hypoxia-induced changes of mRNAs, encoding overrepresented proteins. a mRNAs encoding proteins overrepresented in hypoxic secretomes.
b mRNAs encoding proteins overrepresented in normoxic secretomes. mRNA fold changes are expressed using 2-ΔΔCt, n = 18
Fig. 3 Hypoxia-induced changes of G-CSF mRNA and protein in ADSCs
secretomes. Protein concentration was measured by ELISA and
expressed as a mean of fold changes calculated for each donor.
mRNA fold changes are expressed using 2-ΔΔCt, n = 16 for both
analyses. G-CSF granulocyte-colony stimulating factor, ADSCs
adipose-derived mesenchymal stromal cells, ELISA enzyme-linked
immunosorbent assay
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BDNF, NGF and GDNF may account for the beneficial
action of these cells or their secretomes on the regener-
ation of brain and peripheral nerves [4, 6]. Uncovering
the content of neurotrophins produced by ADSCs
allows the development of a defined preparation of re-
combinant factors, which might substitute cell therapy
in the treatment of neurodegenerative disorders in the
future. Such enrichment of ADSCs secretome with neu-
rotrophins is not surprising and is in line with the loca-
tion of MSCs in close proximity to peripheral nerves in
vivo [36].
The in vivo decrease of oxygen tension below its
physiological level (2-9 % O2 for ADSCs) can trigger re-
generation processes [37–39]. Cells within a damaged
area respond to hypoxia by stabilization of hypoxia indu-
cible factor-1 (HIF-1α) [40], which binds to HIF-1 re-
sponse elements and drives the expression of mRNA
and miR encoding genes [41, 42]. In our study we dem-
onstrate that hypoxia stimulates the expression and
secretion of angiogenic proteins, including EGF-like
EDIL, RNASE4 and adrenomedullin. Ribonuclease 4 was
not previously reported as a target of HIF-1a; however, it
shares a common promoter with angiogenin, which is
regulated by this transcription factor. Previously, angio-
genin was found in MSC secretomes [12]. Here we dem-
onstrate that RNASE4 prevails in the ADSCs secretome
and might be responsible for angiogenic and anti-apoptotic
activities of these cells [43]. This is consistent with known
mechanisms of long-term adaptation to hypoxia and sup-
ports our previous findings suggesting that hypoxia causes
simultaneous up-regulation of angiogenesis stimulators
together with down-regulation of its inhibitors in ADSCs
[3, 16]. Prolonged hypoxia also led to the disappearance of
proteins regulating osteogenesis and ECM remodeling,
such as cartilage-associated protein (uniprot ID#O75718)
and osteoglycin (uniprot ID #P20774). This is consistent
with previous reports, indicating that low O2 concentration
suppresses osteogenic differentiation of MSCs [44, 45].
This is also in line with a study of Fraizer TP et al., which
nicely quantified the level of proteins in the ADSCs secre-
tomes and demonstrates that exposure of these cells to low
O2 reduces ECM components [46].
Conclusions
Taken together our results suggest that human ADSCs,
defined as CD90+/CD73+/CD105+/CD45-/CD31-/PDG
FRbeta+/NG2+/CD146 + (−) cells, secrete a large array
of proteins, the most represented group being comprised
of extracellular matrix components. The number of se-
creted proteins is largely unaffected by prolonged hypoxia.
Variability in the secretion of several proteins from cul-
tured ADSCs of individual subjects suggests that these cells
exist as a heterogeneous population containing functionally
distinct subtypes, which differ in numbers between donors.
Despite the fact that this requires further investigation, the
present study provides a basis for further elucidation of the
functional heterogeneity of these cells.
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Additional file 1: Table S1. ADSC donor and culture characteristics.
Table S2. Common proteins identified in all secretomes of normoxic
ADSCs. Table S4. Proteins identified in 1–10 secretomes of normoxic
ADSCs. Table S5. List of extracellular matrix proteins found in secretomes
of normoxic ADSCs. Table S6. List of proteins involved in blood vessel
development, which were found in secretomes of normoxic ADSCs.
Table S7. List of proteins involved in neuron differentiation, which
were found in secretomes of normoxic ADSCs. (DOCX 118 kb)
Additional file 2: Figure S1. Representative images of ADSCs undergoing
adipogenic or osteogenic differentiation. A1-A7. – Cells incubated in
adipogenesis inducing medium for 27 days. C1-C7. - Cells incubated in
osteogenesis inducing medium for 21 day. A, B. – Cells stained with Oil-red
O to detect lipid accumulations. C, D. - Cells stained with Alizarin red S to
detect calcium accumulations. Nuclei were counterstained by hematoxilin.
Scale = 100 μm. (TIFF 1643 kb)
Additional file 3: Figure S2. Representative flow cytometry charts and
plots of additional surface markers expression on ADSC obtained from
eight donors (#2-9). A. - Expression of pericyte markers, PDGFRβ and NG2
glycoprotein. Pink areas – specific antibodies, blue areas – isotype antibodies.
B. – Expression of CD146 together with CD34 or CD31. (TIFF 262 kb)
Additional file 4: Table S3. Data of transcriptome profiling of normoxic
ADSCs. (DOCX 87 kb)
Additional file 5: Figure S3. ADSC response to hypoxia. A. –
Representative Western blots showing the accumulation of HIF-1alpha
after the incubation at 1 % O2 during 48 h. B. – Real time PCR analysis of VEGF
mRNA in hypoxic and normoxic ADSCs (n = 20, * - p<0.05 vs. normoxia).
(TIFF 100 kb)
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